Grand Central Investment Group Veracyte, Inc. Transaction History
Grand Central Investment Group
- $71.7 Million
- Q3 2022
Shares
3 transactions
Others Institutions Holding VCYT
# of Institutions
257Shares Held
81.7MCall Options Held
43KPut Options Held
82K-
Vanguard Group Inc Valley Forge, PA7.38MShares$159 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA7.37MShares$159 Million0.03% of portfolio
-
Black Rock Inc. New York, NY7.21MShares$155 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.04MShares$152 Million1.11% of portfolio
-
State Street Corp Boston, MA4.33MShares$93.2 Million0.0% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $1.54B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...